Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: Effect of a mercaptoacetic acid/ N-isopropylacrylamide molar ratio

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 1273-1285

  Lai, Jui Yang ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chain transfer agent; Gelatin; Glaucoma; Ocular drug delivery; Poly(N isopropylacrylamide)

Indexed keywords

ANTIGLAUCOMA AGENT; CYANAMIDE; GELATIN; MATRIX METALLOPROTEINASE; PILOCARPINE; POLY(N ISOPROPYLACRYLAMIDE); THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ARTICLE; BIODEGRADABILITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; GEL; GLAUCOMA; HISTOCOMPATIBILITY; INTRAOCULAR PRESSURE; MOLECULAR WEIGHT; NONHUMAN; PHASE TRANSITION; PUPIL; TEMPERATURE SENSITIVITY;

CHAIN TRANSFER AGENT; GELATIN; GLAUCOMA; OCULAR DRUG DELIVERY; POLY(N-ISOPROPYLACRYLAMIDE);

ACRYLAMIDES; ACRYLIC RESINS; ADMINISTRATION, OPHTHALMIC; ANIMALS; CATTLE; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, CORNEAL; GELATIN; GLAUCOMA; HYDROGELS; INTRAOCULAR PRESSURE; MIOTICS; MOLECULAR WEIGHT; MUSCARINIC AGONISTS; PHASE TRANSITION; PILOCARPINE; PUPIL; RABBITS; TEMPERATURE; THIOGLYCOLATES;

EID: 84886683813     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S53759     Document Type: Article

References (43)

1. Roses AD. Pharmacogenetics and the practice of medicine. Nature. 2000;405(6788)857-865.
2. Kopecek J. Polymer-drug conjugates: origins, progress to date and future directions. Adv Drug Deliv Rev. 2013;65(1):49-59.
3. Anitha A, Chennazhi K P, Nair S V, Jayakumar R. 5-fourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedi-cine for breast cancer. J Biomed Nanotechnol. 2012;8(1):29-42.
4. Babu A, Jeyasubramanian K, Gunasekaran P, Murugesan R. Gelatin nanocarrier enables effcient delivery and phototoxicity of hypocrellin B against a mice tumour model. J Biomed Nanotechnol. 2012;8(1): 43-56.
5. Cover NF, Lai-Yuen S, Parsons AK, Kumar A. Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and effcacy. Int J Nanomedicine. 2012;7:2411-2419.
6. Sahib MN, Abdulameer SA, Darwis Y, Peh KK, Tan YT. Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations. Drug Des Devel Ther. 2012;6:29-42.
7. Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS. Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy. Int J Nanomedicine. 2012;7:4077-4088.
8. Li J, He Z, Yu S, et al. Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J Biomed Nanotechnol. 2012;8(5):809-817.
9. Fundueanu G, Constantin M, Oanea I, Harabagiu V, Ascenzi P, Simionescu BC. Prediction of the appropriate size of drug molecules that could be released by a pulsatile mechanism from pH/ thermoresponsive microspheres obtained from preformed polymers. Acta Biomater. 2012;8(3):1281-1289.
10. Schmaljohann D, Oswald J, Jørgensen B, Nitschke M, Beyerlein D, Werner C. Thermo-responsive PNiPAAm-g-PEG films for controlled cell detachment. Biomacromolecules. 2003;4(6):1733-1739.
11. Stayton PS, Shimoboji T, Long C, et al. Control of protein-ligand recognition using a stimuli-responsive polymer. Nature. 1995;378(6556): 472-474.
12. Lai JY, Lu PL, Chen KH, Tabata Y, Hsiue GH. Effect of charge and molecular weight on the functionality of gelatin carriers for corneal endothelial cell therapy. Biomacromolecules. 2006;7(6):1836-1844.
13. Lai JY, Chen KH, Hsu WM, Hsiue GH, Lee YH. Bioengineered human corneal endothelium for transplantation. Arch Ophthalmol. 2006;124(10):1441-1448.
14. Lai JY, Chen KH, Hsiue GH. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials. Transplantation. 2007;84(10):1222-1232.
15. Chou F Y, Lai JY, Shih CM, Tsai MC, Lue SJ. In vitro biocompatibility of magnetic thermo-responsive nanohydrogel particles of poly(N-isopropylacrylamide-co-acrylic acid) with Fe3O4 cores: effect of particle size and chemical composition. Colloids Surf B Biointerfaces. 2013;104:66-74.
16. Hsiue GH, Chang RW, Wang CH, Lee SH. Development of in situ thermosensitive drug vehicles for glaucoma therapy. Biomaterials. 2003;24(13):2423-2430.
17. Liu L, Sheardown H. Glucose permeable poly (dimethyl siloxane) poly(N-isopropyl acrylamide) interpenetrating networks as ophthalmic biomaterials. Biomaterials. 2005;26(3):233-244.
18. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release. 2007;120(3): 186-194.
19. Lai JY, Hsieh AC. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine. Biomaterials. 2012;33(7):2372-2387.
20. Ohya S, Matsuda T. Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artifcial extracellular matrix: molecular and formulation parameters vs cell proliferation potential. J Biomater Sci Polym Ed. 2005;16(7):809-827.
21. Chen J P, Cheng TH. Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondro-cytes and meniscus cells. Macromol Biosci. 2006;6(12):1026-1039.
22. Ma DH, Lai JY, Cheng HY, Tsai CC, Ye HLK. Carbodiimide cross-linked amniotic membranes for cultivation of limbal epithelial cells. Biomaterials. 2010;31(25):6647-6658.
23. Lai JY, Wang T P, Li YT, Tu IH. Synthesis, characterization and ocular biocompatibility of potential keratoprosthetic hydrogels based on photopolymerized poly(2-hydroxyethyl methacrylate)-co-poly(acrylic acid). J Mater Chem. 2012;22:1812-1823.
24. Lai JY, Tu IH. Adhesion, phenotypic expression, and biosynthetic capacity of corneal keratocytes on surfaces coated with hyaluronic acid of different molecular weights. Acta Biomater. 2012;8(3):1068-1079.
25. Lai JY, Li YT. Functional assessment of cross-linked porous gelatin hydrogels for bioengineered cell sheet carriers. Biomacromolecules. 2010;11(5):1387-1397.
26. Lai JY, Ma DH, Lai MH, Li YT, Chang RJ, Chen LM. Characterization of cross-linked porous gelatin carriers and their interaction with corneal endothelium: biopolymer concentration effect. PLoS One. 2013;8(1): e54058.
27. Lai JY. Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use. J Mater Sci Mater Med. 2010;21(6):1899-1911.
28. Joffe KM, Raymond JE, Chrichton A. Motion coherence perimetry in glaucoma and suspected glaucoma. Vision Res. 1997;37(7):955-964.
29. Takei YG, Aoki T, Sanui K, Ogata N, Okano T, Sakurai Y. Temperature-responsive bioconjugates. I. Synthesis of temperature-responsive oligomers with reactive end groups and their coupling to biomolecules. Bioconjug Chem. 1993;4(1):42-46.
30. Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H, Sorsa T. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma. 2005;14(1): 64-69.
31. Lai JY, Lin PK, Hsiue GH, Cheng HY, Huang SJ, Li YT. Low bloom strength gelatin as a carrier for potential use in retinal sheet encapsulation and transplantation. Biomacromolecules. 2009;10(2):310-319.
32. Lai JY. Evaluation of cross-linking time for porous gelatin hydrogels on cell sheet delivery performance. J Mech Med Biol. 2011;11:967-981.
33. Lai JY, Li YT, Cho CH, Yu TC. Nanoscale modifcation of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering. Int J Nanomedicine. 2012;7:1101-1114.
34. Sharma G, Italia JL, Sonaje K, Tikoo K, Ravi Kumar MN. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. J Control Release. 2007;118(1):27-37.
35. Hsiue GH, Guu JA, Cheng CC. Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine. Biomaterials. 2001;22(13): 1763-1769.
36. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release. 2005;109(1-3):256-274.
37. Lu PL, Lai J Y, Tabata Y, Hsiue GH. A methodology based on the "anterior chamber of rabbit eyes" model for noninvasively determining the biocompatibility of biomaterials in an immune privileged site. J Biomed Mater Res A. 2008;86(1):108-116.
38. Lai JY. The role of bloom index of gelatin on the interaction with retinal pigment epithelial cells. Int J Mol Sci. 2009;10(8):3442-3456.
39. Lai JY, Li YT. Evaluation of cross-linked gelatin membranes as delivery carriers for retinal sheets. Mater Sci Eng C Mater Biol Appl. 2010;30(5): 677-685.
40. Lai J Y, Li YT. Influence of cross-linker concentration on the functionality of carbodiimide cross-linked gelatin membranes for retinal sheet carriers. J Biomater Sci Polym Ed. 2011;22(1-3):277-295.
41. Lai JY, Hsiue GH. Functional biomedical polymers for corneal regenerative medicine. React Funct Polym. 2007;67(11): 1284-1291.
42. Guadana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348-360.
43. Bensinger R, Shin DH, Kass MA, Podos SM, Becker B. Pilocarpine ocular inserts. Invest Ophthalmol. 1976;15(12):1008-1010.